{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:50:10Z","timestamp":1790895010658,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":3065,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.virol.2005.01.019","type":"journal-article","created":{"date-parts":[[2005,3,18]],"date-time":"2005-03-18T09:42:40Z","timestamp":1111138960000},"page":"87-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein"],"prefix":"10.1016","volume":"335","author":[{"given":"Maria P.","family":"Rodriguez-Carreno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Botten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Smith-Nixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Buchmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Lindsay","family":"Whitton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2005.01.019_bib1","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1128\/jvi.71.3.2292-2302.1997","article-title":"A multivalent minigene vaccine, containing B cell, CTL, and Th epitopes from several microbes, induces appropriate responses in vivo, and confers protection against more than one pathogen","volume":"71","author":"An","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.01.019_bib2","first-page":"16","article-title":"Multivalent minigene vaccines against infectious disease","volume":"1","author":"An","year":"1999","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.virol.2005.01.019_bib3","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/377632a0","article-title":"Protection against mycoplasma infection using expression-library immunization","volume":"377","author":"Barry","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.virol.2005.01.019_bib4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/viro.1996.0248","article-title":"The phylogeny of New World (Tacaribe complex) arenaviruses","volume":"219","author":"Bowen","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.virol.2005.01.019_bib5","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/ni806","article-title":"T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens","volume":"3","author":"Brehm","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virol.2005.01.019_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0042-6822(81)90137-9","article-title":"Monoclonal antibodies to lymphocytic choriomeningitis virus and Pichinde virus generation characterization and cross reactivity with other arenaviruses","volume":"113","author":"Buchmeier","year":"1981","journal-title":"Virology"},{"key":"10.1016\/j.virol.2005.01.019_bib7","series-title":"Biosafety in Microbiological and Biomedical Laboratories","first-page":"196","article-title":"Arboviruses, arenaviruses, and filoviruses assigned to biosafety level 4","year":"1999"},{"key":"10.1016\/j.virol.2005.01.019_bib8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0140-6736(87)90767-7","article-title":"Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever","volume":"2","author":"Clegg","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2005.01.019_bib9","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/bmj.285.6347.1003","article-title":"A case of Lassa fever: experience at St Thomas's Hospital","volume":"285","author":"Cooper","year":"1982","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.virol.2005.01.019_bib10","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1084\/jem.176.6.1681","article-title":"Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex","volume":"176","author":"Corr","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2005.01.019_bib11","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/jama.1990.03450160063030","article-title":"Acute sensorineural deafness in Lassa fever","volume":"264","author":"Cummins","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.virol.2005.01.019_bib12","first-page":"103","article-title":"Mucosal immunization with Salmonella typhimurium expressing Lassa virus nucleocapsid protein cross-protects mice from lethal challenge with lymphocytic choriomeningitis virus","volume":"4","author":"Djavani","year":"2001","journal-title":"J. Hum. Virol."},{"key":"10.1016\/j.virol.2005.01.019_bib13","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0140-6736(85)90752-4","article-title":"Safe intensive-care management of a severe case of Lassa fever with simple barrier nursing techniques","volume":"2","author":"Fisher-Hoch","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2005.01.019_bib14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1073\/pnas.86.1.317","article-title":"Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene","volume":"86","author":"Fisher-Hoch","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2005.01.019_bib15","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1128\/JVI.74.15.6777-6783.2000","article-title":"Effective vaccine for Lassa fever","volume":"74","author":"Fisher-Hoch","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.01.019_bib16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0035-9203(84)90107-X","article-title":"The use of Lassa fever convalescent plasma in Nigeria","volume":"78","author":"Frame","year":"1984","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2005.01.019_bib17","first-page":"28","article-title":"Pichinde virus infections in Syrian hamsters","author":"Gee","year":"1978","journal-title":"Can. Fed. Biol. Soc."},{"key":"10.1016\/j.virol.2005.01.019_bib18","doi-asserted-by":"crossref","first-page":"8286","DOI":"10.1128\/JVI.74.18.8286-8291.2000","article-title":"Direct ex vivo kinetic and phenotypic analyses of CD8+ T cell responses induced by DNA immunization","volume":"74","author":"Hassett","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.01.019_bib19","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1128\/JVI.74.6.2620-2627.2000","article-title":"Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization","volume":"74","author":"Hassett","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.01.019_bib20","first-page":"28","article-title":"Immunogenic and protective characteristics of recombinant Lassa virus NP protein","volume":"47","author":"Ignat'ev","year":"2002","journal-title":"Vopr. Virusol."},{"key":"10.1016\/j.virol.2005.01.019_bib21","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1128\/iai.32.2.872-880.1981","article-title":"Pathogenesis of a Pichinde virus strain adapted to produce lethal infections in guinea-pigs","volume":"32","author":"Jahrling","year":"1981","journal-title":"Infect. Immun."},{"key":"10.1016\/j.virol.2005.01.019_bib22","doi-asserted-by":"crossref","first-page":"829","DOI":"10.4269\/ajtmh.1983.32.829","article-title":"Case control study of Mastomys natalensis and humans in Lassa virus infected households in Sierra-Leone","volume":"32","author":"Keenlyside","year":"1983","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2005.01.019_bib23","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1128\/jvi.63.10.4311-4316.1989","article-title":"Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection","volume":"63","author":"Klavinskis","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.01.019_bib24","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1128\/jvi.67.6.3497-3506.1993","article-title":"Cross-protection against lymphocytic choriomeningitis virus mediated by a CD4+ T-cell clone specific for an envelope glycoprotein epitope of Lassa virus","volume":"67","author":"La Posta","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.01.019_bib25","first-page":"75","article-title":"Lassa fever","volume":"262","author":"McCormick","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.virol.2005.01.019_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJM198601023140104","article-title":"Lassa fever. Effective therapy with ribavirin","volume":"314","author":"McCormick","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2005.01.019_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.1890370102","article-title":"Inactivated Lassa virus elicits a non protective immune response in rhesus monkeys","volume":"37","author":"McCormick","year":"1992","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2005.01.019_bib28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/bioinformatics\/15.3.211","article-title":"DIALIGN 2: improvement of the segment-to-segment approach to multiple sequence alignment","volume":"15","author":"Morgenstern","year":"1999","journal-title":"Bioinformatics"},{"key":"10.1016\/j.virol.2005.01.019_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0042-6822(89)90525-4","article-title":"Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus","volume":"171","author":"Morrison","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.virol.2005.01.019_bib30","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1128\/JVI.75.14.6273-6278.2001","article-title":"Common antiviral cytotoxic T-lymphocyte epitope for diverse arenaviruses","volume":"75","author":"Oldstone","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.01.019_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF01309452","article-title":"The nucleoprotein of Pichinde virus expressed by a vaccinia\u2013Pichinde virus recombinant partially protects hamsters from lethal virus challenge","volume":"139","author":"Ozols","year":"1994","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virol.2005.01.019_bib32","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1128\/jvi.69.4.2574-2582.1995","article-title":"DNA vaccination against persistent viral infection","volume":"69","author":"Pedroza Martins","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.01.019_bib33","doi-asserted-by":"crossref","first-page":"11677","DOI":"10.1128\/JVI.75.23.11677-11685.2001","article-title":"Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses","volume":"75","author":"Pushko","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.01.019_bib34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s002510050595","article-title":"SYFPEITHI: database for MHC ligands and peptide motifs","volume":"50","author":"Rammensee","year":"1999","journal-title":"Immunogenetics"},{"key":"10.1016\/j.virol.2005.01.019_bib35","doi-asserted-by":"crossref","first-page":"8497","DOI":"10.1128\/jvi.71.11.8497-8503.1997","article-title":"DNA immunization: ubiquitination of a viral protein enhances CTL induction, and antiviral protection, but abrogates antibody induction","volume":"71","author":"Rodriguez","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.01.019_bib36","doi-asserted-by":"crossref","first-page":"5174","DOI":"10.1128\/JVI.72.6.5174-5181.1998","article-title":"DNA immunization with minigenes: low frequency of memory CTL and inefficient antiviral protection are rectified by ubiquitination","volume":"72","author":"Rodriguez","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.01.019_bib37","doi-asserted-by":"crossref","first-page":"7399","DOI":"10.1128\/JVI.75.16.7399-7409.2001","article-title":"Two overlapping subdominant epitopes identified by DNA immunization induce protective CD8+ T-cell populations with differing cytolytic activities","volume":"75","author":"Rodriguez","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.01.019_bib38","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1084\/jem.179.6.1933","article-title":"Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses","volume":"179","author":"Selin","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2005.01.019_bib39","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1084\/jem.188.9.1705","article-title":"Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations","volume":"188","author":"Selin","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2005.01.019_bib40","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/icb.1997.63","article-title":"Multi-epitope DNA vaccines","volume":"75","author":"Suhrbier","year":"1997","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.virol.2005.01.019_bib41","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1073\/pnas.92.13.5845","article-title":"Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design","volume":"92","author":"Thomson","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2005.01.019_bib42","doi-asserted-by":"crossref","first-page":"631","DOI":"10.4269\/ajtmh.1971.20.631","article-title":"Pichinde virus, a new virus of the Tacaribe group from Colombia","volume":"20","author":"Trapido","year":"1971","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2005.01.019_bib43","article-title":"Animal models for LCMV","volume":"36","author":"von Herrath","year":"2000","journal-title":"Curr. Protoc. Immun., Suppl."},{"key":"10.1016\/j.virol.2005.01.019_bib44","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4049\/jimmunol.132.1.469","article-title":"Generation of memory cell mediated immune responses after secondary infection of mice with Pichinde virus","volume":"132","author":"Walker","year":"1984","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2005.01.019_bib45","series-title":"Recombinant and synthetic vaccines","first-page":"429","article-title":"The use of minigenes in antiviral vaccination","author":"Whitton","year":"1994"},{"key":"10.1016\/j.virol.2005.01.019_bib46","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1128\/jvi.63.10.4303-4310.1989","article-title":"Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity","volume":"63","author":"Whitton","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.01.019_bib47","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/jvi.67.1.348-352.1993","article-title":"A \u201cstring-of-beads\u201d vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge","volume":"67","author":"Whitton","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.01.019_bib48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/mpat.1995.0047","article-title":"Persistent infection of mice with Pichinde virus associated with failure to thrive","volume":"19","author":"Wright","year":"1995","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.virol.2005.01.019_bib49","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1128\/jvi.69.4.2684-2688.1995","article-title":"DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection","volume":"69","author":"Yokoyama","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.01.019_bib50","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1574-695X.1996.tb00290.x","article-title":"DNA immunization: effects of vehicle and route of administration on the induction of protective antiviral immunity","volume":"14","author":"Yokoyama","year":"1996","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.virol.2005.01.019_bib51","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0264-410X(97)00213-2","article-title":"DNA immunization can stimulate florid local inflammation, and the antiviral immunity induced varies depending on injection site","volume":"15","author":"Yokoyama","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2005.01.019_bib52","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/S0264-410X(98)00065-6","article-title":"Protection by minigenes: a novel approach of DNA vaccines","volume":"16","author":"Yu","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2005.01.019_bib53","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.4049\/jimmunol.154.8.4010","article-title":"Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein","volume":"154","author":"Zarozinski","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2005.01.019_bib54","doi-asserted-by":"crossref","first-page":"11911","DOI":"10.1128\/JVI.76.23.11911-11919.2002","article-title":"Neonates mount robust and protective adult-like CD8+ T cell responses to DNA vaccines","volume":"76","author":"Zhang","year":"2002","journal-title":"J. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682205000401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682205000401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:34:44Z","timestamp":1758584084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682205000401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0042682205000401"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2005.01.019","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2005.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}